Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study
Benjamin Chaigne(Centre National de la Recherche Scientifique), Alexandre Bense(Université Paris Cité), Anh Tuan Dinh‐Xuan(Hôpital Cochin), David Launay(Inserm), Vincent Cottin(Université Claude Bernard Lyon 1), Bertrand Dunogué(Hôpital Cochin), É. Hachulla(Centre Hospitalier Universitaire de Lille), S. Palat(Centre Hospitalier Universitaire de Limoges), F. Aubourg(Hôpital Cochin), G. Pugnet(Hôpital Rangueil), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique), A. Bérezné(Université Paris Cité), Yannick Allanore(Inserm), C. Agard(Centre National de la Recherche Scientifique), Emmanuel Chatelus(Laboratoire National de Référence), A. Hot(Hospices Civils de Lyon), Alain Lescoat(Inserm), S. Berthier(Maison des Sciences sociales et des Humanités de Dijon), Luc Mouthon(Université Paris Cité), Sébastien Rivière(Sorbonne Université)
Cited by 3
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k